Clinical trial

Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in…

NCT00349791 · Warner Chilcott, Industry · Completed

Key facts

NCT number NCT00349791
Title Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido
Official title A Study to Evaluate the Efficacy/Safety of Transdermal Testosterone for 24 Weeks in Naturally Menopausal Women With Hypoactive Sexual Desire Disorder on Oral Hormone Replacement Therapy.
Lead sponsor Warner Chilcott, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Hypoactive Sexual Desire Disorder (HSDD)
Intervention type Drug
Interventions Testosterone Transdermal System, Placebo patch
Enrollment 549
Start date Jun 1, 2002
Primary completion Oct 1, 2003
Completion Oct 1, 2003
First posted Jul 10, 2006
Last update posted Apr 17, 2013
Countries Australia, Canada, United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies